Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Annexon
(NASDAQ:ANNX)
Intraday
$4.49
-0.055
[-1.21%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$4.49
-0.055
[-1.21%]
Last update: 8:07AM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Annexon Stock (NASDAQ:ANNX)
Annexon Stock (NASDAQ: ANNX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 11, 2024
Needham Reiterates Buy on Annexon, Maintains $16 Price Target
Benzinga Newsdesk
-
Apr 11, 2024, 7:17AM
Tuesday, April 09, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Apr 9, 2024, 1:35PM
Friday, April 05, 2024
Annexon Inc Entered Sales Agreement Relating To Sale Of Shares Of Common Stock, May Offer Shares Of Common Stock, From Time To Time, For $100M
Benzinga Newsdesk
-
Apr 5, 2024, 4:13PM
Wednesday, April 03, 2024
Cantor Fitzgerald Reiterates Overweight on Annexon
Benzinga Newsdesk
-
Apr 3, 2024, 9:33AM
Monday, April 01, 2024
Wells Fargo Maintains Overweight on Annexon, Maintains $12 Price Target
Benzinga Newsdesk
-
Apr 1, 2024, 11:56AM
JP Morgan Maintains Overweight on Annexon, Raises Price Target to $13
Benzinga Newsdesk
-
Apr 1, 2024, 9:53AM
Thursday, March 28, 2024
B of A Securities Maintains Buy on Annexon, Raises Price Target to $10
Benzinga Newsdesk
-
Mar 28, 2024, 2:14PM
Wednesday, March 27, 2024
Annexon shares are trading higher after the company reported better-than-expected Q4 EPS results. Also, Wells Fargo maintained an Overweight rating on the stock and raised its price target from $11 to $12.
Benzinga Newsdesk
-
Mar 27, 2024, 11:56AM
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Mar 27, 2024, 10:03AM
HC Wainwright & Co. Maintains Buy on Annexon, Maintains $30 Price Target
Benzinga Newsdesk
-
Mar 27, 2024, 9:03AM
Wells Fargo Maintains Overweight on Annexon, Raises Price Target to $12
Benzinga Newsdesk
-
Mar 27, 2024, 8:56AM
Needham Reiterates Buy on Annexon, Maintains $16 Price Target
Benzinga Newsdesk
-
Mar 27, 2024, 6:53AM
Tuesday, March 26, 2024
Annexon Filed For Mixed Shelf Offering Of Up To $400M
Charles Gross
-
Mar 26, 2024, 5:08PM
Annexon Q4 EPS $(0.36) Beats $(0.48) Estimate
Happy Mohamed
-
Mar 26, 2024, 4:30PM
Friday, March 22, 2024
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Mar 22, 2024, 2:39PM
Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Mar 22, 2024, 10:08AM
Thursday, March 14, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Mar 14, 2024, 9:06AM
Wednesday, March 13, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Mar 13, 2024, 1:31PM
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Mar 13, 2024, 1:18PM
Monday, March 04, 2024
Needham Reiterates Buy on Annexon, Maintains $16 Price Target
Benzinga Newsdesk
-
Mar 4, 2024, 6:57AM
HC Wainwright & Co. Reiterates Buy on Annexon, Maintains $30 Price Target
Benzinga Newsdesk
-
Mar 4, 2024, 6:51AM
Friday, March 01, 2024
Annexon shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight.
Benzinga Newsdesk
-
Mar 1, 2024, 12:54PM
JP Morgan Upgrades Annexon to Overweight, Maintains Price Target to $11
Benzinga Newsdesk
-
Mar 1, 2024, 6:53AM
Monday, January 08, 2024
Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Avi Kapoor
-
Jan 8, 2024, 5:37AM
Sunday, January 07, 2024
Annexon Outlines 2024 Priorities With Late-Stage Clinical Milestones Across Upstream Complement Portfolio For Autoimmune, Ophthalmic And Neurodegenerative Diseases; Says Recent $125M Financing Extends Operating Runway Into Q2 2026
Benzinga Newsdesk
-
Jan 7, 2024, 8:21PM
Friday, December 29, 2023
$1M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Avi Kapoor
-
Dec 29, 2023, 6:36AM
Thursday, December 21, 2023
Nasdaq Gains 100 Points; CarMax Earnings Top Views
Avi Kapoor
-
Dec 21, 2023, 2:23PM
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Dec 21, 2023, 1:01PM
Why Is Complement-Mediated Focused Annexon Stock Trading Higher Today?
Vandana Singh
-
Dec 21, 2023, 11:07AM
Market-Moving News for December 21st
Benzinga Newsdesk
-
Dec 21, 2023, 8:46AM
Needham Reiterates Buy on Annexon, Maintains $16 Price Target
Benzinga Newsdesk
-
Dec 21, 2023, 7:00AM
B of A Securities Upgrades Annexon to Buy, Raises Price Target to $6
Benzinga Newsdesk
-
Dec 21, 2023, 6:45AM
Wednesday, December 20, 2023
Annexon Reports Pricing Of $125M Public Offering Of Common Stock
Benzinga Newsdesk
-
Dec 20, 2023, 5:29PM
Annexon Outlines Its Global Registrational Program For ANX007 For Treatment Of Patients With Geographic Atrophy
Benzinga Newsdesk
-
Dec 20, 2023, 5:13PM
Monday, November 13, 2023
Needham Maintains Buy on Annexon, Lowers Price Target to $16
Benzinga Newsdesk
-
Nov 13, 2023, 6:32PM
Recap: Annexon Q3 Earnings
Benzinga Insights
-
Nov 13, 2023, 6:35AM
Annexon Q3 EPS $(0.43) Vs $(0.51) YoY, Cash Balance of $165.3M to Support Runway into Q2 2025
Benzinga Newsdesk
-
Nov 13, 2023, 6:33AM
Tuesday, October 10, 2023
Annexon Announces Clinical and Regulatory Progress for ANX005 Pivotal Program in Guillain-Barré Syndrome (GBS)
Benzinga Newsdesk
-
Oct 10, 2023, 6:31AM
Tuesday, August 22, 2023
The Latest Analyst Ratings for Annexon
Benzinga Insights
-
Aug 22, 2023, 10:00AM
Cantor Fitzgerald Reiterates Overweight on Annexon, Maintains $13 Price Target
Benzinga Newsdesk
-
Aug 22, 2023, 9:19AM
Tuesday, August 08, 2023
Cantor Fitzgerald Maintains Overweight on Annexon, Lowers Price Target to $13
Benzinga Newsdesk
-
Aug 8, 2023, 1:34PM
HC Wainwright & Co. Reiterates Buy on Annexon, Maintains $30 Price Target
Benzinga Newsdesk
-
Aug 8, 2023, 6:38AM
Monday, August 07, 2023
Needham Reiterates Buy on Annexon, Maintains $24 Price Target
Benzinga Newsdesk
-
Aug 7, 2023, 2:34PM
Thursday, August 03, 2023
Chief Medical Officer at Annexon Acquires Company Stock Options Worth 275,000 Shares
Benzinga Insights
-
Aug 3, 2023, 11:01AM
Tuesday, August 01, 2023
Cantor Fitzgerald Reiterates Overweight on Annexon, Maintains $18 Price Target
Benzinga Newsdesk
-
Aug 1, 2023, 9:27AM
Needham Reiterates Buy on Annexon, Maintains $24 Price Target
Benzinga Newsdesk
-
Aug 1, 2023, 6:13AM
Monday, July 31, 2023
Analyst Ratings for Annexon
Benzinga Insights
-
Jul 31, 2023, 10:00AM
HC Wainwright & Co. Reiterates Buy on Annexon, Maintains $30 Price Target
Benzinga Newsdesk
-
Jul 31, 2023, 6:09AM
Sunday, July 30, 2023
Annexon Announced ARCHER Trial Results At ASRS 2023 Highlighting Potential of ANX007 As A Differentiated Treatment For Geographic Atrophy; Additional Analyses Support Consistent Protection From Vision Loss
Charles Gross
-
Jul 30, 2023, 2:16PM
Friday, July 28, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Jul 28, 2023, 5:32PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch